Clinical trial
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Recruiting now · Early Phase 1 · 1 countries · Registry ID NCT05219799
What this study is about
The purpose of this project is to examine key mechanisms contributing to sex-differences in hypoxic vasodilation and the impact of obesity, with particular emphasis on the sympathetic nervous system.
Basic eligibility
Full registry criteria
Treatments and study arms
Propranolol Hydrochloride
Regional forearm blockade of β-adrenergic receptors at 20 mcg/dL/min via brachial artery catheter during normoxia and hypoxia exposures
Isoproterenol
Dose response (1, 3, 6, and 12 ng/dL/min) regional infusion to assess β-adrenergic receptor responsiveness
Phentolamine Mesylate
This infusion will be for 10 min before baseline measurement (12 mcg/dL/min) and continue the infusion at a maintenance rate (5 mcg/dL/min).
Norepinephrine
Regional forearm infusion at 8 ng/dL/min via brachial artery catheter during normoxia and hypoxia exposures
Primary outcomes
Vascular conductance is an index of vascular tone and is measured using a technique called venous occlusion plethysmography.
Study locations
1 locations were listed when this page was built. The first 40 are shown.